actionsantemondiale, Author at Action Santé Mondiale

Joint Statement on the Revision of the Pharmaceutical Legislation

Recommendations

Promoting transparent and needs-driven EU R&D policies

Joint Statement on the Revision of the Pharmaceutical Legislation

Joint Statement on the Revision of the Pharmaceutical Legislation by associations representing healthcare providers, patients, healthcare professionals and payers Enhancing patients’ access to high-quality and affordable…

actionsantemondiale9 November 2022

An essential check-list for the new EU Global Health Strategy: 16 points that will make it or break it

Recommendations

Cooperation for development EU

An essential check-list for the new EU Global Health Strategy: 16 points that will make it or break it

The feedback for the European Commission’s public consultation about the renewal of its global health strategy (GHS) is now closed. We have been following this…

actionsantemondiale7 November 2022

Joint declaration

Promoting transparent and needs-driven EU R&D policies

Together for Access to Medicines

The members of the European Alliance for Responsible R&D and Affordable Medicines have joint their voices in the Joint Rome Declaration to raise awareness and…

actionsantemondiale20 October 2022

GHA’s recommendation ahead of the FIF Board Meeting

Recommendations

Fight against pandemics

GHA’s recommendation ahead of the FIF Board Meeting

The Covid-19 pandemic has highlighted the urgent need for collective actions and additional investment in pandemic prevention, preparedness, and response. To address the gaps, under…

actionsantemondiale7 October 2022

We believe in alternative funding and pricing models that can encourage pharmaceutical companies to innovate and to charge reasonable prices

Blog series

Promoting transparent and needs-driven EU R&D policies

We believe in alternative funding and pricing models that can encourage pharmaceutical companies to innovate and to charge reasonable prices

By Ella Weggen, Global health advocate at Wemos

actionsantemondiale28 September 2022

It is clear that transparency creates trust, and that the Political institutions should be irreproachable in that regard

Blog series

Promoting transparent and needs-driven EU R&D policies

It is clear that transparency creates trust, and that the Political institutions should be irreproachable in that regard

By Tilly Metz, Member of the EU Parliament

actionsantemondiale28 September 2022

Promoting transparent and needs-driven EU R&D policies

More transparency in the pharmaceutical sector: is the EU up for it?

Approved in November 2020, the EU Pharma Strategy aims to build up more access to affordable medicines, boost competitiveness, innovation and sustainability of the pharmaceutical…

actionsantemondiale28 September 2022

Blog series

Transparency is key to unlocking better policies

By Ellen T'Hoen, lawyer and director of Medicine Law & Policy

actionsantemondiale28 September 2022

The EU confirms its leadership in the fight against pandemics

Press release

Fight against pandemics, HIV/AIDS, TB & Malaria, Whatever It Takes

The EU confirms its leadership in the fight against pandemics

The Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria held its 7th Replenishment Conference today in New York. In 20 years, its investments have saved…

actionsantemondiale21 September 2022

Reactive

Cooperation for development EU, Promoting transparent and needs-driven EU R&D policies

SOTEU 2022: blackout on health

Today, Ursula von der Leyen delivered her State of the European Union speech. The President of the Commission reiterated the EU’s unwavering support to Ukraine…

actionsantemondiale14 September 2022

Joint Statement on the Revision of the Pharmaceutical Legislation

An essential check-list for the new EU Global Health Strategy: 16 points that will make it or break it

Together for Access to Medicines

GHA’s recommendation ahead of the FIF Board Meeting

We believe in alternative funding and pricing models that can encourage pharmaceutical companies to innovate and to charge reasonable prices

It is clear that transparency creates trust, and that the Political institutions should be irreproachable in that regard

More transparency in the pharmaceutical sector: is the EU up for it?

Transparency is key to unlocking better policies

The EU confirms its leadership in the fight against pandemics

SOTEU 2022: blackout on health

Addresses

Social Networks

Contact us